Modeling mitigation of influenza epidemics by baloxavir

Here, the authors implement a mathematical model that describes how Baloxavir antiviral-induced inhibition of influenza virus replication in infected individuals affects the spread of the virus during epidemics, suggesting that both the scaling up and acceleration of treatment would avert substantia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhanwei Du, Ciara Nugent, Alison P. Galvani, Robert M. Krug, Lauren Ancel Meyers
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/fcf4d646137b4d9aa9dd957c0593cd7e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fcf4d646137b4d9aa9dd957c0593cd7e
record_format	dspace
spelling	oai:doaj.org-article:fcf4d646137b4d9aa9dd957c0593cd7e2021-12-02T18:24:50ZModeling mitigation of influenza epidemics by baloxavir10.1038/s41467-020-16585-y2041-1723https://doaj.org/article/fcf4d646137b4d9aa9dd957c0593cd7e2020-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-16585-yhttps://doaj.org/toc/2041-1723Here, the authors implement a mathematical model that describes how Baloxavir antiviral-induced inhibition of influenza virus replication in infected individuals affects the spread of the virus during epidemics, suggesting that both the scaling up and acceleration of treatment would avert substantial influenza morbidity and mortality every year.Zhanwei DuCiara NugentAlison P. GalvaniRobert M. KrugLauren Ancel MeyersNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-6 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Zhanwei Du Ciara Nugent Alison P. Galvani Robert M. Krug Lauren Ancel Meyers Modeling mitigation of influenza epidemics by baloxavir
description	Here, the authors implement a mathematical model that describes how Baloxavir antiviral-induced inhibition of influenza virus replication in infected individuals affects the spread of the virus during epidemics, suggesting that both the scaling up and acceleration of treatment would avert substantial influenza morbidity and mortality every year.
format	article
author	Zhanwei Du Ciara Nugent Alison P. Galvani Robert M. Krug Lauren Ancel Meyers
author_facet	Zhanwei Du Ciara Nugent Alison P. Galvani Robert M. Krug Lauren Ancel Meyers
author_sort	Zhanwei Du
title	Modeling mitigation of influenza epidemics by baloxavir
title_short	Modeling mitigation of influenza epidemics by baloxavir
title_full	Modeling mitigation of influenza epidemics by baloxavir
title_fullStr	Modeling mitigation of influenza epidemics by baloxavir
title_full_unstemmed	Modeling mitigation of influenza epidemics by baloxavir
title_sort	modeling mitigation of influenza epidemics by baloxavir
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/fcf4d646137b4d9aa9dd957c0593cd7e
work_keys_str_mv	AT zhanweidu modelingmitigationofinfluenzaepidemicsbybaloxavir AT ciaranugent modelingmitigationofinfluenzaepidemicsbybaloxavir AT alisonpgalvani modelingmitigationofinfluenzaepidemicsbybaloxavir AT robertmkrug modelingmitigationofinfluenzaepidemicsbybaloxavir AT laurenancelmeyers modelingmitigationofinfluenzaepidemicsbybaloxavir
_version_	1718378135192338432

Modeling mitigation of influenza epidemics by baloxavir

Ejemplares similares